| Citation: |
XU Minmin, WANG Jian, YUAN Kangzheng, HE Shenghu, LIU Fangmei, LIAO Qingchi, WANG Daxin, DENG Min. Effectiveness and safety of “one-stop” surgery of left atrial appendage closure and percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2022, 26(20): 99-104. DOI: 10.7619/jcmp.20221817
|
To evaluate the effectiveness and safety of percutaneous left atrial appendage closure (LAAC) combined with percutaneous coronary intervention (PCI) in patients with coronary heart disease (CAD) and atrial fibrillation (AF).
A retrospective study was performed in 10 patients with CAD and AF who underwent "one-stop procedure" of LAAC combined with PCI. Baseline data, perioperativetreatment, occurrence of serious complications and postoperative antithrombotic regiments were recorded. Echocardiographic parameters and Canadian Cardiovascular Society (CCS) angina classification were compared before operation and at 1 month and 1 year after operation. Routine postoperative telephone or outpatient follow-up was performed, and the medications, thromboembolism, major bleeding events, and survival of patients were recorded.
The atrial fibrillation stroke risk score (CHA2DS2-VASc score) and bleeding risk score were (4.8±1.1) and (3.8±1.0); the diameter of left atrial appendage opening was (24.6±4.3) mm, the diameter of left atrial appendage anchoring area was (22.8±2.8) mm, and the depth of left atrial appendage was (32.2±4.4) mm. Lambre devices were successfully placed in all 10 patients, and stent implantation was performed in the diseased culprit vessel. No patient had severe complications such as thromboembolism or bleeding during the perioperative period. During follow-up of (18.7±3.9) months, all patients survived, no patient had myocardial infarction, ischemic stroke, hemorrhagic stroke, or thromboembolic events. One patient had massive bleeding and 2 patients had minor bleeding. There were no significant differences in left atrial internal diameter, left ventricular ejection fraction, pulmonary artery pressure, mitral regurgitation, tricuspid regurgitation, and aortic regurgitation of patients 1 month after operation compared with pre-operation (P>0.05). At 1 month after operation, the CCS angina grade showed a significant difference compared with that before operation (P < 0.05). There were no significant differences in left atrial internal diameter, pulmonary artery pressure, mitral regurgitation, tricuspid regurgitation, and aortic regurgitation of patients 1 year after operation compared with pre-operation (P>0.05). There were statistically significant differences in left ventricular ejection fraction and angina pectoris CCS classification of patients 1 year after operation compared with pre-operation(P < 0.05).
The "one-stop" procedure of LAAC (Lambre closure) combined with PCI in patients with CAD and AF is feasible, safe, and effective.
| [1] |
HINDRICKS G, POTPARA T, DAGRES N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC[J]. Eur Heart J, 2020, 42(5): 373-498.
|
| [2] |
MICHNIEWICZ E, MLODAWSKA E, LOPATOWSKA P, et al. Patients with atrial fibrillation and coronary artery disease-Double trouble[J]. Adv Med Sci, 2018, 63(1): 30-35. doi: 10.1016/j.advms.2017.06.005
|
| [3] |
LOPES R D, HEIZER G, ARONSON R, et al. Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation[J]. N Engl J Med, 2019, 380(16): 1509-1524. doi: 10.1056/NEJMoa1817083
|
| [4] |
于凯, 张珍侠, 王媛. 心房颤动合并冠心病患者行经皮冠状动脉介入术后3种抗栓治疗疗效比较[J]. 实用临床医药杂志, 2020, 24(12): 39-41. doi: 10.7619/jcmp.202012011
|
| [5] |
VRANCKX P, VALGIMIGLI M, ECKARDT L, et al. Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial[J]. Lancet, 2019, 394(10206): 1335-1343. doi: 10.1016/S0140-6736(19)31872-0
|
| [6] |
OSMANCIK P, HERMAN D, NEUZIL P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation[J]. J Am Coll Cardiol, 2020, 75(25): 3122-3135. doi: 10.1016/j.jacc.2020.04.067
|
| [7] |
WANG Y, WU D, MA J, et al. The feasibility and safety of "one-stop" left atrial appendage closure and percutaneous coronary intervention in atrial fibrillation patients with significant coronary artery disease (PCI-LAAC study)[J]. Am J Cardiovasc Dis, 2021, 11(5): 679-687.
|
| [8] |
戴雯莉, 姚可欣, 蒋超, 等. 长期透析的终末期肾病合并心房颤动患者行左心耳封堵术的安全性与有效性初探[J]. 中华心血管病杂志, 2021, 49(9): 880-885. doi: 10.3760/cma.j.cn112148-20210608-00487
|
| [9] |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 中国左心耳封堵预防心房颤动卒中专家共识(2019)[J]. 中华心血管病杂志, 2019, 47(12): 937-955. doi: 10.3760/cma.j.issn.0253-3758.2019.12.002
|
| [10] |
JANUARY C T, WANN L S, CALKINS H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons[J]. Circulation, 2019, 140(2): e125-e151.
|
| [11] |
GLIKSON M, WOLFF R, HINDRICKS G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion-an update[J]. Europace, 2020, 22(2): 184. doi: 10.1093/europace/euz258
|
| [12] |
CHEN S, CHUN K R J, BORDIGNON S, et al. Left atrial appendage occlusion using LAmbre amulet and watchman in atrial fibrillation[J]. J Cardiol, 2019, 73(4): 299-306. doi: 10.1016/j.jjcc.2018.10.010
|
| [13] |
HUANG H, LIU Y, XU Y, et al. Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study[J]. JACC Cardiovasc Interv, 2017, 10(21): 2188-2194. doi: 10.1016/j.jcin.2017.06.072
|
| [14] |
KUMAR S, LIM E, COVIC A, et al. Anticoagulation in concomitant chronic kidney disease and atrial fibrillation: JACC review topic of the week[J]. J Am Coll Cardiol, 2019, 74(17): 2204-2215. doi: 10.1016/j.jacc.2019.08.1031
|
| [15] |
LIU B, LUO J, GONG M, et al. Five-year outcomes and cardiac remodeling following left atrial appendage occlusion[J]. Clin Interv Aging, 2021, 16: 655-663. doi: 10.2147/CIA.S296639
|
| [16] |
KOOK H, YU C W, JEONG H S, et al. P1668Comparison of clinical outcomes between left atrial appendage occlusion with dual antiplatelet therapy versus conventional antithrombotic therapy in patients with atrial fibrillation undergoing PCI[J]. Eur Heart J, 2018, 39(suppl_1): ehy565. P1668.
|
| [17] |
KÖRMENDY D, PILGRIM T, PULVER C, et al. Outcome after simultaneous PCI and left atrial appendage occlusion[J]. Cardiovascular Medicine, 2015, 18(3): 96-102. doi: 10.4414/cvm.2015.00300
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: